Skip to main content
ICPE 2023 Main banner
Final Program


ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Bruce C. Carleton, PharmD, FCP, FISPE

Professor
University of British Columbia
Vancouver, Canada

Bruce Carleton is Director of the MedSafe Clinic at British Columbia Children’s and St. Paul's Hospitals in Vancouver, which is devoted to characterizing serious adverse drug reactions and defining culprit drugs so that patients and health care providers have clear messages about what drugs are safe and can be used in the future. He is Professor and Chair of the Division of Translational Therapeutics in the Department of Pediatrics, Faculty of Medicine, University of British Columbia (UBC). He is also a Senior Clinician Scientist at the BC Children’s Hospital Research Institute and runs the Canadian Pharmacogenomics Network for Drug Safety, a Canadian and International Network devoted to the study of the biological mechanisms of serious adverse drug reactions.

He holds faculty appointments at UBC in the Department of Medical Genetics, School of Population and Public Health, Centre for Health Services and Policy Research and the Faculty of Pharmaceutical Sciences. He is also an adjunct professor at the School of Health Information Science at University of Victoria.

Dr. Carleton also serves the US Government as a Special Government Employee to advise the Advisory Committee for Pharmaceuticals and Clinical Pharmacology of the FDA. He is a fellow of the American College of Clinical Pharmacology and the International Society of Pharmacoepidemiology.




Disclosure information not submitted.

Presentation(s):